Journal article
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Abstract
There is uncertainty regarding the effectiveness and occurrence of thromboembolic events in patients treated with prothrombin complex concentrates (PCCs) for the management of major bleeding events (MBEs) on rivaroxaban or apixaban. We investigated the effectiveness of PCCs given for the management of MBEs in patients on rivaroxaban or apixaban. Between 1 January 2014 and 1 October 2016, we prospectively included patients on rivaroxaban or …
Authors
Majeed A; Ågren A; Holmström M; Bruzelius M; Chaireti R; Odeberg J; Hempel E-L; Magnusson M; Frisk T; Schulman S
Journal
Blood, Vol. 130, No. 15, pp. 1706–1712
Publisher
American Society of Hematology
Publication Date
October 12, 2017
DOI
10.1182/blood-2017-05-782060
ISSN
0006-4971